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Abstract 
Iron deficiency anemia is currently the most widespread micronutrient deficiency affecting 
nearly 1.5 billion people globally i.e. around 1/3 of the whole population. About 70% of 
Indians are found to be anemic out of which, 95% of anemia is due to iron deficiency. 
Infants, preschool children and adolescents are at greatest risk of developing iron deficiency 
and its resultant anemia. It is mostly seen in rural areas and in communities of low socio-
economic group. Because of this reason IDA was selected for this study to assess the efficacy 
of Dhatriloha. So to evaluate the effect of Dhatriloha in the management of Iron deficiency 
anemia in children aged between 1-6years the present study has been taken up. 30 patients, 
from Kaumarabhritya OPD and IPD of SDMCA & H, Hassan, fulfilling the inclusion and 
exclusion criteria were selected in to study. Dhatriloha was administered in a dose of 250mg 
twice daily for a period of 60 days. The cases were recorded according to the case performa 
and observations were recorded. Symptoms were scored and statistically analyzed for any 
change before and after the study. In the group statistically highly significant change (P = 
<0.001) was observed in the signs and symptoms of IDA. There was a statistically highly 
significant response in hemoglobin concentration in the group (P =<0.001).  
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Introduction: 
Anemia is defined as a reduction of 
the red blood cell volume or hemoglobin 
concentration and hematocrit below the 
range of values occurring in healthy 
persons.Anemia resulting from lack of 
sufficient iron for synthesis of hemoglobin 
is the most common hematological disease 
of infancy and childhood and this is called 
as Iron Deficiency Anemia (IDA). 
Iron deficiency anemia is currently 
the most widespread micronutrient 
deficiency and affects nearly 1.5 billion 
people globally. Presently available data 
has shown that one-third of world’s 
population suffers from iron deficiency 
anemia and of which 90 percent lives in 
the third world countries. About 70% of 
Indians are found to be anemic. 74% of 
children between the age group of 6 to 35 
months are anemic.  
The iron released from the 
senescent red cells during the first 8 to 12 
weeks of life (a period of quiescent 
erythropoiesis) is stored in the body and 
helps maintain erythropoiesis up to 4 to 6 
months in a normal term infant and up to 2 
to 3 months in the low birth weight infant. 
Normal infants at birth have about 75 mg 
of iron per kg body weight, two-thirds of 
which is present in red blood cells. Infants 
and children should continue to absorb 0.8 
to 1.0 mg of iron daily to reach the adult 
body stores of 4 to 5 grams. Iron stores are 
highest during infancy during period of 
rapid growth. Iron is also required more in 
first few years of life and during 
adolescence. 
The dietary iron comes from two 
sources: Heme and non-heme, later being 
the major source of iron in diet and is 
found in varying degrees in all foods of 
plant origin. Heme iron is present in meat, 
fish and poultry, but the intake of these 
Ragamala KC et al., Dhatriloha in the management of Iron deficiency Anemia 
75 
products is generally low. Heme iron is 
better absorbed (35%) than non-heme iron 
(~5%) and is not influenced by dietary 
factors.  
Additional sources of iron in the 
diet include the exogenous sources 
originating from soil dust, water and 
cooking of foods in iron pots but the 
bioavailability of iron is less and the 
contribution insignificant. Good sources of 
iron in the diet include pulses, dals, green 
leafy vegetable, bajra, dates, nuts, jaggery, 
meat and fish. Administration of 50mg of 
vitamin C increases iron absorption by 
two-fold.  
Iron stores in the body such as 
hemosiderin in the liver and bone marrow 
are diminished. Thereafter, serum ferritin 
level falls to less than 10 ng/ml followed 
by a decrese in the level of serum iron and 
increase in the total iron-binding capacity. 
Free erythrocyte porphyrin level rises. 
Microcytic hypochromic anemia occurs 
and the activity of iron-containing 
enzymes diminishes. 
Causes of Iron Deficiency Anemia 
include decreased Iron Stores (Preterm, 
small-for-dates, twins), decreased intake / 
assimilation (Delayed weaning, 
malnutrition, Iron poor diet etc, Increased 
Losses (GI bleeding etc) and Increased 
Demands (Prematurity, LBW etc) 
Management includes Eradication 
of underlying cause, Correction of Anemia 
by oral iron therapy and in severe cases 
parenteral iron therapy. 
The present study is planned to 
supplement the iron to the patients of IDA 
with the Ayurvedic Medicine which 
contains iron as one of the ingredient along 
with other herbal ingredients. So for the 
study Dhatriloha, an iron containing 
preparation is selected for the study. 
 
Aims and objectives of the study: 
To study the effect of Dhatriloha in 
the management of Iron deficiency 
Anemia in Children below 6 years of age. 
 
 
Materials and Methods:  
Source of data:  
Diagnosed cases of Panduroga 
were included from Kaumarabhritya OPD 
and IPD of S.D.M.C.A and Hospital, 
Hassan.  
 
Methods of collection of data:  
Thirty patients who were fulfilling 
the diagnosis and inclusion criteria were 
selected for the study.  
 
Selection of patients and method of 
study:  
By following the inclusion and 
exclusion criteria, 30 children presenting 
characteristics features of Panduroga were 
randomly included in the present study. 
Such selected children were examined 
thoroughly and record was made on the 
assessment criteria as per the case sheet 
specially prepared for the purpose.  
 
Inclusion criteria:  
 Patients presenting with classical 
signs and symptoms of IDA 
 Children with hemoglobin 
percentage between 8 to 12 gm/ dl  
 Patients of both sex between the 
age group of 1 to 6 years  
Exclusion criteria:  
 Patients with severe Anemia due to 
systemic disorders.  
 Hemorrhagic diathesis like 
Hemophilia, ITP, Vit. K deficiency 
etc.  
 Hereditary disorders like 
Thalassaemia, Sideroblasticanemia. 
Etc.  
 
Duration of study: The period of study 
was for two months 
 
Assessment criteria:  
 Assessment was analyzed on the 
basis of improvement in the 
clinical features.  
 The assessment was based on the 
laboratory investigations conducted 
before and after treatment.  
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Laboratory investigations:  
 Blood: HB%, TC, DC, ESR, 
Peripheral smear, Serum ferritin (If 
needed)  
 Stools: Microscopic  
 Urine: Routine, microscopic.  
 
Collection of drugs:  
All the drugs of Dhatriloha both 
herbal and mineral were collected from the 
SDM pharmacy, Udupi for the 
pharmaceutical process. 
 
Drugs:  
1. Amalakichurna – 100 gms  
2. Lohabhasma -- 100 gms  
3. Haridrachurna -- 100 gms  
4. Trikatuchurna -- 33 gms each  
5. Amalakikashaya – as per need for 
bhavana  
 
Method: 
All the above drugs each of 100 
gms was taken in a khalva and powdered 
finely. Then it was triturated with 200 ml 
of Amalakikashaya for 3 hours for 3days. 
Then vatis were prepared of pea size and 
allowed to dry under shade.  
 
Dosage:  
Selected thirty patients were given 
Dhatriloha compound. The dosage was 
given as 250 mg twice a day for a period 
of 2 months. 
 
Grading of the Assessment criteria:  
Weakness: 
 No weakness - 0  
 Weakness not affecting his daily 
activities - 1  
 Weakness affecting his daily 
activities - 2  
 Activities reduced due to weakness 
- 3.  
Fatigue: 
 No Fatigue - 0. 
 Fatigue not affecting his daily 
activities - 1  
 Fatigue affecting his daily 
activities - 2  
 Activities reduced due to weakness 
- 3.  
Exertional Dyspnoea :  
 No Exertional Dyspnoea - 0  
 Mild dyspnoea with normal 
activities - 1  
 Dyspnoea stops his daily activities 
intermittently - 2  
 Dyspnoea stops his daily activities 
frequently - 3  
Palpitation:  
 No Palpitation - 0.  
 Mild Palpitation with normal 
activities - 1.  
 Palpitation with daily activities - 2  
 Palpitation during rest - 3.  
 
Pallor:  
 No Pallor - 0.  
 Conjunctiva slightly pale, nail and 
other mucus membrane not pale - 1  
 Conjunctiva pale, nail and other 
mucus membrane slightly pale - 2.  
 Conjunctiva, mucus membrane and 
nails pale – 3 
 
Assessment of the total efficacy of the 
therapy: 
Response of Clinical Manifestations:  
1) Marked response: When the relief 
is partially observed between 75-
99.9 % in both signs and 
symptoms. 
2) Moderate response: When the 
relief is partially observed during 
the treatment i.e. getting relief in 
about 50-75 % of both signs and 
symptoms collectively or 
individually.  
3) Mild response: When the relief is 
about 25-50 % in signs and 
symptoms. 
4) Unchanged: In whom there is no 
relief found. 
Laboratory Investigations: 
1) Marked Response : Increase of 
Hb% between 2-3gm% 
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2) Moderate response : Increase of 
Hb% between 1-2gm%  
3) Mild Response : Increase of Hb% 
between 0-1gm%  
4) Unchanged : : No change in Hb% 
Observations and Results: 
Analysis was done from the point of 
view of: 
1. Clinical condition of the patients before 
and after treatment procedure.  
2. Hematological estimation before and 
after treatment procedure.  
Of the 30 patients studied, 66.67 % 
patients were in 1-3 years age groups, 
followed by 33.33 % in age group of 4-6 
years (Table No.1). 66.67 % patients were 
Male and 33. 33 % were Females (Table 
No.2). 36.36% were of middle class, 
54.54% patients were belonging to poor 
class of the society and 9.10% patients 
were belonging to High class of the society 
(Table No.3). 70 % patients were Non-
vegetarian having, 30 % patients were 
Vegetarian. (Table No.4) 
In a sample size of 30 patients, 10 
patients (33.33%) were shown marked 
improvement, 16 patients (53.33%) 
showed moderate improvement, 4 patients 
(13.33%) showed mild improvement. 
 
Table 1: Age wise distribution of 
patients 
Age (in 
years) 
No of 
patients 
% 
1-3 22 66.67 
4-6 11 33.33 
 
Table 2: Sex wise distribution of 
patients 
Sex  No of 
patients 
% 
Male 22 66.67 
Female 11 33.33 
 
Table 3: Economic status wise 
distribution of patients 
Economic 
status 
No of 
patients 
% 
Poor 18 54.54 
Middle 12 36.36 
Rich 3 9.10 
 
Table 4: Diet wise distribution of 
patients 
Diet No of 
patients 
% 
Vegetarian 10 30 
Mixed 23 70 
 
 
Results: 
Table 5: Effects of Therapy on Hridrava of 30 patients of Pandu roga:  
Symptom n Mean % SD SE ‘t’ value ‘p’ value 
BT AT 
Weakness 30 1.3 0.4 69.23 0.48 0.08 10.25 <0.001 
Fatigue 30  1.166  0.4  65.71  0.430  0.07  9.76  < 0.001  
Exertional 
dyspnoea 
30  0.4  0.066  83.33  0.479  0.087  3.80  < 0.001  
Palpitation  30  0.5  0.06  86.66  0.50  0.09  4.70  < 0.001  
Pallor 30  1.63  0.96  40.8  0.53  0.09  6.82  < 0.001  
Hb % 30  9.5  10.38  8.77  0.506  0.092  9.51  < 0.001  
 
Table 6: Over All Effect of Therapy  
Result  No. of Patients  %  
Complete  0  0  
Marked  10  33.33  
Moderate  16  53.33  
Mild  4  13.33  
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Unchanged  0  0  
 
DISCUSSION:  
Out of the 30 patients 33.3% showed 
marked improvement, 53.3% showed 
moderate and 13.3% showed mild 
improvement in their symptoms.  
In this series of 30 patients of iron 
deficiency anemia 33.33% patients showed 
marked improvement, 53.33% patients 
showed moderate improvement and 
13.33% patients showed mild 
improvement. 
There was considerable decrease in 
signs and symptoms of iron deficiency 
anemia after treatment. This improvement 
can be attributed to property of Dhatriloha 
and thereby increased the hemoglobin of 
the body. 
Administration of Dhatriloha 
through the oral route showed no side 
effects such as colicky pain, gastric 
distress, constipation, diarrhea, nausea and 
vomiting.  
Overall picture of the results 
obtained in the study suggests that 
Dhatriloha increase about one gm/dl of 
hemoglobin by the two months of the 
treatment. 
 
Probable Mode of Action of Drug:  
The ingredients of Dhatriloha are as 
follows:  
Amalaki and Loha are main 
ingredients in this yoga and hence the 
name Dhatriloha mentioned in Bhaishajya 
Ratnavali.  
Action of the medicine mainly 
depends upon its constituents like Rasa, 
Guna, Veerya, Vipaka, Prabhava etc.  
Rasa: Amalaki is an Amla rasa 
pradhana and can increase Raktha and 
hence in Rakthalpatha, Amla preeti is 
seen. It also being a rich source of Vit.C 
helps in absorption of iron. Hence it is 
used in anemia along with iron compound. 
Shunti, Marica, Pippali and Haridra are 
Katu rasa pradhana dravyas which can 
promote Agni by their Deepana & Pachana 
properties which can nullify the 
Agnimandhya, Aruchi like laksanas of 
Pandu roga. They also provide an acidic 
media for the better absorption of Loha 
bhasma (Iron).  
Guna: Laghu, Ruksha, Snigdha 
gunas of dravyas can revert back the 
conditions like Dhatu Shaithilya, Gourava.  
Virya: Most of dravyas of yoga have 
Sheeta Virya.  
Vipaka: Most of dravyas have 
Madhura Vipaka viz; Amalaki, Shunti, 
Pippali, Loha bhasma. Madhura, Sheeta 
guna are BalaVarnakara, Dhatuvardhaka, 
Preenana and Jeevana.  
Prabhava: Pramathya property of 
Marica may help in clearing the 
Srothoavarodha. Haridra acts as a 
Krimighna and Loha bhasma can directly 
increase the Raktha dhatu (Hematinic 
effect). Amalaki can act as Rasayana to 
prevent Ojokshaya.  
Dosaghnata: All the ingredients of 
yoga are Tridoshahara and Kapha 
Vatashamaka. As we know, one among 
Kaphaja vyadhis is Pandu roga. Vitiated 
Kapha in Twacha produces Shweta 
avabhasata and vitiated Vata in the body is 
responsible for producing laksanas of 
Pandu roga like Karshya, DhatuKshaya, 
Shaithilya etc., to nullify the Kapha and 
Vata these dravyas are very much 
important.  
Hence by considering above points 
Dhatriloha might have produced beneficial 
effect in the signs and symptoms of the 
disease as well as increasing the 
hemoglobin concentration.  
 
CONCLUSION: 
Dhatriloha is an important drug 
described in classics which is 
therapeutically useful.  
Dhatriloha is effective in the 
management of Iron deficiency anemia in 
children. 
Dhatriloha has haematinic effect. 
No adverse effects like constipation, 
gastric irritation etc., by administration of 
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Dhatriloha were seen during the period of 
study.  
Dhatriloha can be considered as 
safest drug than other iron preparations in 
IDA due to the presence of Dhatri, rich in 
vitamin C.  
For complete cure of IDA, a long 
term use of Dhatriloha is required.  
Finally it can be concluded that 
Dhatriloha has a positive role in the 
management of disease Iron Deficiency 
Anaemia in children. 
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 Figure 1: Raw Drugs  Figure 2: Mixing of the Ingredients 
 
 
 
 
            
Figure 3: Mixing of the ingredients Figure 4: Dhatrilouha pills 
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